FREmedica Partners With CellCore at ECO24

2 years ago

VANCOUVER, BC / ACCESSWIRE / April 29, 2024 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) is excited…

Hypha Labs Names Craig Ellins Chief Science Officer

2 years ago

LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Hypha Labs, Inc. (OTC Pink:DIGP) has announced that it has…

Specialty Revenue Cycle Management Firms Revolutionize Complex Claims Processing Through Automation, Garnering Rapid Adoption Among Providers, Black Book Survey

2 years ago

Black Book surveyed nearly 5,000 healthcare providers in a sweeping study of the evolving revenue cycle management IT sector. EnableComp…

Planet 13 Announces OMMU Approval for Proposed Sale of Planet 13 Florida and Acquisition of VidaCann

2 years ago

LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company"),…

AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

2 years ago

Next safety cohort to begin escalated dosing soonOCALA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American:…

Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET

2 years ago

HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the…

SELLAS Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study

2 years ago

– Based on the Efficacy and Safety Data Assessed, the Independent Data Monitoring Committee (IDMC) Recommends Continuation of Phase 3…

GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity

2 years ago

LA JOLLA, CA, April 29, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a…

Cerevance to Participate at Upcoming Investor Conferences

2 years ago

BOSTON, April 29, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system…